4.5 Article

GCN2-Dependent Metabolic Stress Is Essential for Endotoxemic Cytokine Induction and Pathology

期刊

MOLECULAR AND CELLULAR BIOLOGY
卷 34, 期 3, 页码 428-438

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.00946-13

关键词

-

资金

  1. intramural grant from Georgia Regents University
  2. NIH/NIAID [AI092213]
  3. Wellcome Trust Principal Research Fellowship
  4. EU FP7 BetaBat grant [277713]

向作者/读者索取更多资源

Activated inflammatory macrophages can express indoleamine 2,3-dioxygenase (IDO) and thus actively deplete their own tryptophan supply; however, it is not clear how amino acid depletion influences macrophage behavior in inflammatory environments. In this report, we demonstrate that the stress response kinase GCN2 promotes macrophage inflammation and mortality in a mouse model of septicemia. In vitro, enzymatic amino acid consumption enhanced sensitivity of macrophages to the Toll-like receptor 4 (TLR4) ligand lipopolysaccharide (LPS) with significantly increased interleukin 6 (IL-6) production. Tryptophan withdrawal induced the stress response proteins ATF4 and CHOP/GADD153; however, LPS stimulation rapidly enhanced expression of both proteins. Moreover, LPS-driven cytokine production under amino acid-deficient conditions was dependent on GCN2, as GCN2 knockout (GCN2KO) macrophages had a significant reduction of cytokine gene expression after LPS stimulation. To test the in vivo relevance of these findings, monocytic-lineage-specific GCN2KO mice were challenged with a lethal dose of LPS intraperitoneally (i.p.). The GCN2KO mice showed reduced inflammatory responses, with decreased IL-6 and IL-12 expression correlating with significant reduction in animal mortality. Thus, the data show that amino acid depletion stress signals (via GCN2) synergize with proinflammatory signals to potently increase innate immune responsiveness.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

The Akt-mTORC1 pathway mediates Axl receptor tyrosine kinase-induced mesangial cell proliferation

Yuxuan Zhen, Tracy L. McGaha, Fred D. Finkelman, Wen-Hai Shao

Summary: Research indicates that Axl promotes mesangial cell proliferation and phagocytosis of apoptotic cells by activating NF-kappa B and mTORC1, with less impact in other cell types.

JOURNAL OF LEUKOCYTE BIOLOGY (2022)

Article Gastroenterology & Hepatology

N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer

Shiyan Wang, Shanshan Gao, Yong Zeng, Lin Zhu, Yulin Mo, Chi Chun Wong, Yi Bao, Peiran Su, Jianning Zhai, Lina Wang, Fraser Soares, Xin Xu, Huarong Chen, Kebria Hezaveh, Xinpei Ci, Aobo He, Tracy McGaha, Catherine O'Brien, Robert Rottapel, Wei Kang, Jianfeng Wu, Gang Zheng, Zongwei Cai, Jun Yu, Housheng Hansen He

Summary: The study identified a novel oncogenic epitranscriptome axis of YTHDF1-m(6)A-ARHGEF2 that regulates CRC tumorigenesis and metastasis.

GASTROENTEROLOGY (2022)

Review Biotechnology & Applied Microbiology

Pharmacological targeting of endoplasmic reticulum stress in disease

Stefan J. Marciniak, Joseph E. Chambers, David Ron

Summary: Research on drug-like molecules targeting ER stress and UPR has made progress, but limitations still exist. Understanding these limitations is crucial for the development of these molecules into therapeutic drugs.

NATURE REVIEWS DRUG DISCOVERY (2022)

Article Oncology

Restoring FAS Expression via Lipid-Encapsulated FAS DNA Nanoparticle Delivery Is Sufficient to Suppress Colon Tumor Growth In Vivo

Alyssa D. Merting, Dakota B. Poschel, Chunwan Lu, John D. Klement, Dafeng Yang, Honglin Li, Huidong Shi, Eric Chapdelaine, Mitzi Montgomery, Michael T. Redman, Natasha M. Savage, Asha Nayak-Kapoor, Kebin Liu

Summary: The study explores the potential of restoring FAS expression in suppressing colorectal tumor growth. Through the administration of nanoparticles carrying FAS cDNA, FAS expression was successfully restored in tumor cells. In vivo and in vitro experiments confirmed that restored FAS expression could eliminate tumor cells and inhibit tumor growth through FASL-induced immune responses.

CANCERS (2022)

Article Hematology

BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes

Michael C. Zaiken, Ryan Flynn, Katelyn G. Paz, Stephanie Y. Rhee, Sujeong Jin, Fathima A. Mohamed, Asim Saha, Govindarajan Thangavelu, Paul M. C. Park, Matthew L. Hemming, Peter T. Sage, Arlene H. Sharpe, Michel DuPage, Jeffrey A. Bluestone, Angela Panoskaltsis-Mortari, Corey S. Cutler, John Koreth, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, Leo Luznik, Ivan Maillard, Geoffrey R. Hill, Kelli P. A. MacDonald, David H. Munn, Jonathan S. Serody, William J. Murphy, Leslie S. Kean, Yi Zhang, James E. Bradner, Jun Qi, Bruce R. Blazar

Summary: In this study, the efficacy of two inhibitors, JQ5 and JQ1, in improving the pathological processes of chronic graft-versus-host-disease (cGVHD) and bronchiolitis obliterans (BO) was tested in a murine model. The results showed that these inhibitors improved pulmonary function, inhibited the germinal center reaction, and reduced the severity of cutaneous lesions. The study suggests that targeting epigenetic processes in the germinal center could be a viable clinical approach for the treatment of cGVHD.
Article Oncology

Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapy

Nada S. Aboelella, Caitlin Brandle, Ogacheko Okoko, Md Yeashin Gazi, Zhi-Chun Ding, Hongyan Xu, Gregory Gorman, Roni Bollag, Marco L. Davila, Locke J. Bryan, David H. Munn, Gary A. Piazza, Gang Zhou

Summary: This study demonstrates that the use of indomethacin (indo) can enhance the killing effect of genetically modified T cells on cancer cells by increasing death receptor signaling in cancer cells. This provides a rationale for combining indo with genetically modified T cells to intensify tumor cell killing.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Oncology

Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses

Jessica K. Mandula, Shiun Chang, Eslam Mohamed, Rachel Jimenez, Rosa A. Sierra-Mondragon, Darwin C. Chang, Alyssa N. Obermayer, Carlos M. Moran-Segura, Satyajit Das, Julio A. Vazquez-Martinez, Karol Prieto, Ann Chen, Keiran S. M. Smalley, Brian Czerniecki, Peter Forsyth, Richard C. Koya, Brian Ruffell, Juan R. Cubillos- Ruiz, David H. Munn, Timothy I. Shaw, Jose R. Conejo-Garcia, Paulo C. Rodriguez

Summary: The deletion or inhibition of PERK in cancer cells triggers activation of anti-tumor T cell immunity, attenuates tumor growth, and promotes immunogenic cell death. This mechanism provides a potential new target for cancer immunotherapy.

CANCER CELL (2022)

Article Cell Biology

AMPylation and Endoplasmic Reticulum Protein Folding Homeostasis

Luke A. A. Perera, David Ron

Summary: The ER-localized Hsp70 chaperone, BiP, undergoes a rapid and reversible modification called AMPylation, which complements the unfolded protein response in regulating protein folding demand in the ER. This modification is mediated by the enzyme FICD, which also has the ability to deAMPylate BiP. The structural basis of BiP recognition by FICD and the potential physiological significance of BiP AMPylation are also discussed.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2023)

Review Cell Biology

IRF8: Mechanism of Action and Health Implications

Hannah R. Moorman, Yazmin Reategui, Dakota B. Poschel, Kebin Liu

Summary: IRF8 is a transcription factor that plays an important role in myeloid cell differentiation and immune suppressive cells, and it is often silenced in human cancer patients. It regulates cell apoptosis and the expression of Osteopontin, affecting tumor development and treatment.
Article Medicine, Research & Experimental

Infancy-onset diabetes caused by de-regulated AMPylation of the human endoplasmic reticulum chaperone BiP

Luke A. Perera, Andrew T. Hattersley, Heather P. Harding, Matthew N. Wakeling, Sarah E. Flanagan, Ibrahim Mohsina, Jamal Raza, Alice Gardham, David Ron, Elisa De Franco

Summary: Mutation in the FICD gene leads to dysfunction of the endoplasmic reticulum, resulting in cell loss and diabetes mellitus. The study suggests that regulating the activity of FICD may provide therapeutic benefits for treating related diseases.

EMBO MOLECULAR MEDICINE (2023)

Article Cell Biology

IRF8 Regulates Intrinsic Ferroptosis through Repressing p53 Expression to Maintain Tumor Cell Sensitivity to Cytotoxic T Lymphocytes

Dakota B. Poschel, Mercy Kehinde-Ige, John D. Klement, Dafeng Yang, Alyssa D. Merting, Natasha M. Savage, Huidong Shi, Kebin Liu

Summary: In this study, it was found that interferon regulatory factor 8 (IRF8) functions as a regulator of tumor cell sensitivity to intrinsic ferroptosis by repressing p53 expression. Restoring IRF8 expression can suppress tumor growth. In human cancer patients, nivolumab responders have higher IRF8 expression in tumor cells compared to non-responders.
Article Oncology

Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment

John D. Klement, Priscilla S. Redd, Chunwan Lu, Alyssa D. Merting, Dakota B. Poschel, Dafeng Yang, Natasha M. Savage, Gang Zhou, David H. Munn, Padraic G. Fallon, Kebin Liu

Summary: This study found that tumor cell surface PD-L1 does not suppress cytotoxic T lymphocyte activity and has no effect on primary tumor growth. However, deletion of tumor cell surface PD-L1 decreases lung metastasis in a CTL-dependent manner. Depletion of myeloid cells or knocking out PD-1 in myeloid cells impairs PD-L1 promotion of tumor lung metastasis. Single-cell RNA sequencing revealed that PD-L1 engages myeloid cells PD-1 to activate SHP2 and repress the IFN-I-STAT1-CXCL9 pathway to impair CTL recruitment in lung metastasis.

CANCER CELL (2023)

Article Oncology

Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma

Gia-Buu Tran, Jane Ding, Bingwei Ye, Mengling Liu, Yajie Yu, Yunhong Zha, Zheng Dong, Kebin Liu, Sunil Sudarshan, Han-Fei Ding

CANCER RESEARCH (2023)

Article Oncology

5-Fluorouracil Suppresses Colon Tumor through Activating the p53-Fas Pathway to Sensitize Myeloid-Derived Suppressor Cells to FasL+ Cytotoxic T Lymphocyte Cytotoxicity

Yingcui Yang, Mingqing Zhang, Yongdan Zhang, Kebin Liu, Chunwan Lu

Summary: 5-Fluorouracil (5-FU) selectively kills myeloid-derived suppressor cells (MDSCs) and increases cytotoxic T lymphocyte activation, leading to enhanced antitumor immunity in colorectal cancer patients. The molecular mechanism underlying 5-FU's suppression of MDSCs involves the activation of the p53-Fas pathway, which upregulates Fas expression and increases MDSC sensitivity to apoptosis. 5-FU therapy effectively suppresses MDSC accumulation and promotes CTL tumor infiltration.

CANCERS (2023)

Article Immunology

Retinoic acid signaling acts as a rheostat to balance Treg function

Govindarajan Thangavelu, Gabriela Andrejeva, Sara Bolivar-Wagers, Sujeong Jin, Michael C. Zaiken, Michael Loschi, Ethan G. Aguilar, Scott N. Furlan, Chrysothemis C. Brown, Yu-Chi Lee, Cameron McDonald Hyman, Colby J. Feser, Angela Panoskaltsis-Mortari, Keli L. Hippen, Kelli P. MacDonald, William J. Murphy, Ivan Maillard, Geoffrey R. Hill, David H. Munn, Robert Zeiser, Leslie S. Kean, Jeffrey C. Rathmell, Hongbo Chi, Randolph J. Noelle, Bruce R. Blazar

Summary: This study investigated how RA receptor signaling in Tregs influences their function and stability in vivo. The results indicate that RA signaling acts as a rheostat to balance Treg function in inflammatory and noninflammatory conditions.

CELLULAR & MOLECULAR IMMUNOLOGY (2022)

暂无数据